Borderline personality disorder

CMAJ. Canadian Medical Association Journal

Volumn 172, Issue 12, 2005, Pages 1579-1583

  Paris, Joel ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; PARACETAMOL; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANGER; BEHAVIOR THERAPY; BORDERLINE STATE; CASE REPORT; COGNITIVE THERAPY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DRUG OVERDOSE; DYSPHORIA; FEMALE; GROUP THERAPY; HUMAN; MENTAL DISEASE; PERSONALITY DISORDER; POLYPHARMACY; PROGNOSIS; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL ASPECT; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REVIEW; SOCIAL ASPECT; SOCIAL INTERACTION; SUICIDE ATTEMPT;

EID: 20544463858     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.045281     Document Type: Review

References (56)

1. Diagnostic and statistical manual of mental disorders, 4th ed, text revision. Washington: American Psychiatric Association; 2000.
2. Skodol AE, Gunderson JG, Pfohl B, Widiger TA, Livesley WJ, Siever LJ. The borderline diagnosis. I: Psychopathology, comorbidity, and personality structure. Biol Psychiatry 2002;51:936-50.
3. Samuels J, Eaton WW, Bienvenu J, Clayton P, Brown H, Costa PT, et al. Prevalence and correlates of personality disorders in a community sample. Br J Psychiatry 2002;180:536-42.
4. Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiatry 2001;58:590-6.
5. Rutter M. Temperament, personality, and personality development. Br J Psychiatry 1987;150:443-8.
6. Livesley WJ, Jang KL, Vernon PA. Phenotypic and generic structure of traits delineating personality disorder. Arch Gen Psychiatry 1998;55:941-94.
7. Hinshaw SP. Impulsivity, emotion regulation, and developmental psychopathology: specificity versus generality of linkages. Ann N Y Acad Sci 2003;1008:149-59.
8. Torgersen S, Lygren S, Oien PA, Skre I, Onstad S, Edvardsen J, et al. A twin study of personality disorders. Compr Psychiatry 2000;41:416-25.
9. White CN, Gunderson JG, Zanarini MC, Hudson JI. Family studies of borderline personality disorder: a review. Harv Rev Psychiatry 2003;11:8-19.
10. Gurvits IG, Koenigsberg HW, Siever LJ. Neurotransmitter dysfunction in patients with borderline personality disorder. Psychiatr Clin North Am 2000; 23:27-40.
11. Paris J, Zweig-Frank H, Ng F, Schwartz G, Steiger H, Nair V. Neurobiological correlates of diagnosis and underlying traits in patients with borderline personality disorder compared with normal controls. Psychiatry Res 2004;121:239-52.
12. Zanarini MC, Frankenburg FR, Khera GS, Bleichmar J. Treatment histories of borderline inpatients. Compr Psychiatry 2001;42:144-50.
13. Paris J. Childhood trauma as an etiological factor in the personality disorders. J Personal Disord 1997;11:34-49.
14. Zanarini MC. Childhood experiences associated with the development of borderline personality disorder. Psychiatr Clin North Am 2000;23:89-101.
15. Paris J, Zweig-Frank H, Guzder J. Psychological risk factors for borderline personality disorder in female patients. Compr Psychiatry 1994;35:301-5.
16. Monroe SM, Simons AD. Diathesis-stress theories in the context of life stress research. Psychol Bull 1991;110:406-25.
17. Paris J. Social factors in the personality disorders. New York: Cambridge University Press; 1996.
18. Zanarini MC, Gunderson JG, Frankenburg FR. The revised diagnostic interview for borderlines: discriminating BPD from other axis II disorders. J Personal Disord 1989;3:10-8.
19. Gunderson JG, Phillips KA. A current view of the interface between borderline personality disorder and depression. Am J Psychiatry 1991;148:967-75.
20. Henry C, Mitropoulou V, New AS, Koenigsberg HW, Silverman J, Siever LJ. Affective instability and impulsivity in borderline personality and bipolar II disorders: similarities and differences. J Psychiatr Res 2001;35:307-12.
21. Yen S, Shea MT, Sanislow CA, Grilo CM, Skodol AE, Gunderson JG, et al. Borderline personality disorder criteria associated with prospecrively observed suicidal behavior. Am J Psychiatry 2004;161:1296-8.
22. Links PS, Steiner M, Offord DR, Eppel A. Characteristics of borderline personality disorder: a Canadian study. Can J Psychiatry 1988;33:336-40.
23. Siever LJ, Torgersen S, Gunderson JG, Livesley WJ, Kendler KS. The borderline diagnosis. III: Identifying endophenotypes for genetic studies. Biol Psychiatry 2002;51:964-8.
24. Zanarini MC, Gunderson JG, Frankenburg FR. Cognitive features of borderline personality disorder. Am J Psychiatry 1990;147:57-63.
25. Miller FT, Abrams T, Dulit R, Fyer M. Psychotic symptoms in patients with borderline personality disorder and concurrent axis I disorder. Hosp Community Psychiatry 1993;44:59-61.
26. Dowson JH, Sussams P, Grounds AT, Taylor J. Associations of self-reported past "psychotic" phenomena with features of personality disorders. Compr Psychiatry 2000;41:A2-8.
27. Forman EM, Berk MS, Henriques GR, Brown GK, Beck AT. History of multiple suicide attempts as a behavioral marker of severe psychopathology. Am J Psychiatry 2004;161:437-43.
28. Gross R, Olfson M, Gameroff M, Shea S, Feder A, Fuentes M, et al. Borderline personality disorder in primary care. Arch Intern Med 2002;162:53-60.
29. Zanarini NC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, et al. Axis I comorbidity of borderline personality disorder. Am J Psychiatry 1998;155:1733-9.
30. Paris J. Borderline or bipolar? Distinguishing borderline personality disorder from bipolar spectrum disorders. Harv Rev Psychiatry 2004;12:140-5.
31. Gunderson JG. Borderline personality disorder: a clinical guide. Washington: American Psychiatric Press; 2003.
32. Paris J, Zweig-Frank H. A 27 year follow-up of patients with borderline personality disorder. Compr Psychiatry 2001;42:482-7.
33. Zanarini MC, Frankenburg FR, Hennen J, Silk KR. The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder. Am J Psychiatry 2003;160:274-83.
34. Gunderson JG, Morey LC, Stout RL, Skodol AE, Shea MT, McGlashan TH, et al. Major depressive disorder and borderline personality disorder revisited: longitudinal interactions. J Clin Psychiatry 2004;65:1049-56.
35. Paris J. Personality disorders over time, Washington: American Psychiatric Press; 2003.
36. Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF. Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry 1993;50:377-85.
37. Cowdry RW, Gardner DL. Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry 1988;45:111-9.
38. Zanarini MC, Frankenburg FR. Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. J Clin Psychiatry 2001;62:849-54.
39. Zanarini MC, Frankenburg FR, Parachini EA. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. J Clin Psychiatry 2004;65:903-7.
40. Bogenschutz MP, Nurnberg GH. Olanzapine versus placebo in the treatment of borderline personality disorder. J Clin Psychiatry 2004;65:104-9.
41. Salzman C, Wolfson AN, Schatzberg A, Looper J, Henke R, Albanese M, et al. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol 1995;15:23-9.
42. Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry 1997;54:1081-8.
43. Rinne T, van den Brink W, Wouters L, van Dyck R. SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. Am J Psychiatry 2002;159:2048-54.
44. Hollander E, Swann AC, Coccaro EF, Jiang P, Smith TB. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. Am J Psychiatry 2005;162:621-4.
45. Frankenburg FR, Zanarini MC. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study. J Clin Psychiatry 2002;63:442-6.
46. Links PS, Steiner M, Boiago I, Irwin D. Lithium therapy for borderline patients: preliminary findings. J Personal Disord 1990;4:173-81.
47. Zanarini MC, Frankenburg FR. Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psychiatry 2003;160:167-9.
48. Shea MT, Pilkonis PA, Beckham E, Collins JF, Elikin E, Sotsky SM, et al. Personality disorders and treatment outcome in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry 1990;147:711-8.
49. Soloff P. Psychopharmacological treatment of borderline personality disorder. Psychiatr Clin North Am 2000;23:169-92.
50. Linehan MM, Armstrong HE, Suarez A, Allmon D, Heard H. Cognitive behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry 1991;48:1060-4.
51. Bohus M, Haaf B, Simms T, Limberger MF, Schmahl C, Unckel C, et al. Effectiveness of inpatient dialectical behavioral therapy for borderline personality disorder: a controlled trial. Behav Res Ther 2004;42:487-99.
52. Simpson EB, Yen S, Costello E, Rosen K, Begin A, Pistorello J, et al. Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder. J Clin Psychiatry 2004;65:379-85.
53. Verheul R, Van Den Bosch LM, Koeter MW, De Ridder MA, Stijnen T, Van Den Brink W. Dialectical behaviour therapy for women with borderline personality disorder: 12-month, randomised clinical trial in The Netherlands. Br J Psychiatry 2003;182:135-40.
54. Bateman A, Fonagy P. Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry 1999;156:1563-9.
55. Paris J. Chronic suicidality in borderline personality disorder. Psychiatr Serv 2002;53:738-42.
56. Brown MZ, Comtois KA, Linehan MM. Reasons for suicide attempts and nonsuicidal self-injury in women with borderline personality disorder. J Abnorm Psychol 2002;111:198-202.